The  Resorbable Vascular Scaffold Market report from DelveInsight provides an in-depth analysis of  Resorbable Vascular Scaffold, as well as historical and forecasted market trends in the 7MM (the US, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

 

Resorbable Vascular Scaffold Overview

The drawbacks of metallic drug-eluting stents, which permanently cage the arterial wall and hinder normal coronary vasomotion, preclude bypass grafting, and can cause long-lasting foreign-body reactions, were addressed by the development of fully resorbable scaffolds (RS).

The Absorb Bioresorbable Vascular Scaffold (BVS; Abbott Vascular), though many scaffolds have been or are in development, was the first FDA-approved device and was widely anticipated to fulfil interventional cardiologists’ hopes for a transient scaffold that would disappear “when the job was done” and would not restrict further treatment options.

 

Some Key Highlights from the  Resorbable Vascular Scaffold Market Report

• Some of the Resorbable Vascular Scaffold available in the market include balloon-expandable Absorb (Abbott Medical Devices), HeartWare® VAS (Medtronic), LVAD implant (Inova Health Care Services), and others.Major players which are active in the Resorbable Vascular Scaffold market include – Abiomed, Inc., Asahi Kasei Corporation (Evaheart Medical U.S.A., Inc.), Abbott Laboratories (St. Jude Medical, Inc.), Berlin Heart GmbH, Jarvik Heart, Inc., Medtronic Plc., Terumo Corporation, Evaheart, Inc., Calon Cardio, SynCardia Systems LLC
• The drawbacks of metallic stents, such as vascular caging with reduced coronary vasomotion and the impossibility of bypass operations in stented segments, were addressed by the development of Resorbable scaffolds (RS).
• Resorbable Vascular Scaffold market is segmented on the basis of Product Type, By Applications, and End-user.

 

Request sample @ Resorbable Vascular Scaffold Market Insights

 

The market report on  Resorbable Vascular Scaffold includes an overview of the industry as well as a PEST Analysis. The report also examines market drivers, market constraints, and unmet medical needs in order to identify the greatest prospects and analyze the market’s underlying potential.

 

Resorbable Vascular Scaffold Market Drivers

• Growing number of surgeries
• Increasing cardiovascular disease population
• Technological advancements in product development

 

Resorbable Vascular Scaffold Market Barriers

• High product pricing
• Stringent Regulatory Process

 

Resorbable Vascular Scaffold Market

The Resorbable Vascular Scaffolds market report provides an overview of Resorbable Vascular Scaffolds, applications of Resorbable Vascular Scaffolds as well as its advantages and limitations. Additionally, the report provides insight on the Resorbable Vascular Scaffolds market share by segments, along with an assessment of market share by regions, the qualitative and quantitative (USD million, 2019-2027) data will be provided for all the segments in the scope. 

The market is broad, with a large variety of products accessible, and key companies such as Abbott Laboratories, St. Jude Medical, Inc., and Berlin Heart GmbH, among others, are present.

 

Know more about medical devices @ Resorbable Vascular Scaffold Market Outlook

 

Resorbable Vascular Scaffold Key Companies

• Abbott
• Asahi Kasei Corporation (Evaheart Medical U.S.A., Inc.) 
• Abbott Laboratories (St. Jude Medical, Inc.) 
• Berlin Heart GmbH 
• Jarvik Heart, Inc. 
• Medtronic Plc. 
• Terumo Corporation 
• Evaheart, Inc. 
• Calon Cardio 
• SynCardia Systems LLC, and others.

 

Resorbable Vascular Scaffold Unmet Needs

Lengthy product approval process

 

Get more insights @ Resorbable Vascular Scaffold Major Players

 

Scope for the Report

• Coverage: 7MM (the US, EU5 (the UK, Germany, Italy, Spain, and France) and Japan)
• Study Period: 2019-27
• Resorbable Vascular Scaffold Key Companies:  Abiomed, Inc., Asahi Kasei Corporation (Evaheart Medical U.S.A., Inc.), Abbott Laboratories (St. Jude Medical, Inc.), Berlin Heart GmbH, Jarvik Heart, Inc., Medtronic Plc., Terumo Corporation, Evaheart, Inc., Calon Cardio, SynCardia Systems LLC, among others. 

 

Table of Contents 

1.	Key Insights
2.	Executive Summary of  Resorbable Vascular Scaffold
3.	Resorbable Vascular Scaffold: Background and Overview
4.	Resorbable Vascular Scaffold: Regulatory Framework
5.	Resorbable Vascular Scaffold: Reimbursement Scenario
6.	Company Profiles
7.	Resorbable Vascular Scaffold: Competitive Analysis of Listed Products
8.	Resorbable Vascular Scaffold: KOL Views
9.	Resorbable Vascular Scaffold: Market Analysis in 7MM
10.	Country-Wise Market size of  Resorbable Vascular Scaffold   in 7MM
11.	Market Dynamics
12.	PEST Analysis
13.	Conclusion and Future perspective
14.	Appendix
15.	DelveInsight Capabilities
16.	Disclaimer
17.	About DelveInsight

 

Know more about report offerings @ Resorbable Vascular Scaffold Market

 

About DelveInsight

DelveInsight is a leading Healthcare market research and business consulting company recognized for its off-the-shelf syndicated market research reports as well as customized solutions to firms in the healthcare sector.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting